Intravitreal injection treatment involves administering medication into the gel-like part of the eye called the vitreous. Its medical name is intravitreal injection. It is most commonly used for wet age-related macular degeneration, diabetic macular edema, and macular edema caused by retinal vein occlusion. The aim is to control fluid within the retina, vascular leakage, or abnormal vascular activity to preserve vision, improve vision in suitable patients, and slow the progression of the disease.
An injection is not a disease-specific treatment on its own, but a method of administering medication for various retinal diseases. The medication selected, the number of injections required, and the frequency of follow-up examinations are determined according to OCT images, visual acuity, previous treatment response, and the patient's general health. The same medication, number of injections, or visual outcome cannot be expected in every patient.
What Is an Intravitreal Injection?
The medication is administered into the vitreous cavity through the pars plana, entering through the white part of the eye with a very fine needle of approximately 30 gauge. This allows the treatment to reach the retina and macula at a high local concentration. The procedure is performed under sterile conditions after the ocular surface has been prepared with an antiseptic and anesthetic eye drops have been applied. Although the active injection stage is brief, preparation, examination, and patient information are also part of the total procedure time.
Clinical Reality: The purpose of the injection is not always to restore all previously lost vision. Vision may improve in some eyes. In others, the main benefit is preserving existing vision or preventing more rapid vision loss. The outcome is closely related to whether permanent damage has occurred in the retinal cells.
For Which Diseases Are Intravitreal Injections Used?
| Disease | Primary Purpose of the Injection |
|---|---|
| Wet Age-Related Macular Degeneration | To suppress abnormal blood vessel growth and leakage |
| Diabetic Macular Edema | To reduce vascular permeability and edema in the macula |
| Retinal Vein Occlusion | To control macular edema developing after vascular occlusion |
| Myopic Choroidal Neovascularization | To suppress abnormal vascular activity associated with high myopia |
| Uveitis and Inflammatory Macular Edema | To reduce intraocular inflammation and edema in selected patients |
1. Wet Age-Related Macular Degeneration (AMD)
Abnormal blood vessels developing beneath the macula may leak fluid or blood, causing distortion, blurred vision, and dark areas in central vision. Anti-VEGF injections aim to suppress this vascular activity. Scarring and retinal cell loss caused by delayed treatment may limit visual improvement.
2. Diabetic Macular Edema
Vascular damage caused by diabetes may lead to fluid accumulation in the macula. Anti-VEGF treatment is one of the first options for many patients. Controlling blood sugar, blood pressure, kidney function, and blood lipid levels does not replace eye treatment, but it is vitally important for the overall course of the disease.
What Types of Medication Are Injected into the Eye?
Anti-VEGF Medications
VEGF is a growth factor that can increase vascular permeability and abnormal blood vessel development. Anti-VEGF medications aim to reduce leakage and edema by suppressing these pathways. Different active substances such as bevacizumab, ranibizumab, aflibercept, brolucizumab, and faricimab may be used. Regulatory approval status, reimbursement conditions, the type of disease, and the eye's previous response to treatment directly affect medication selection.
Corticosteroid Treatments
Steroid injections or steroid implants placed inside the eye may be considered, particularly in selected cases of diabetic macular edema, retinal vein occlusion, and uveitis. Steroids may reduce inflammation and vascular permeability. However, compared with anti-VEGF treatments, they may increase the risk of elevated intraocular pressure and cataract development to a greater extent.
What Is Considered Before an Intravitreal Injection?
- Visual acuity and the patient's daily visual complaints are evaluated.
- The front and back sections of the eye are examined through biomicroscopy and fundus examination.
- OCT (Optical Coherence Tomography) is used to analyze fluid in the macula, edema, retinal thickness, and structural damage.
- An active infection in or around the eye, such as eyelid inflammation or discharge, requires the injection to be postponed. Blood-thinning medications must never be discontinued without consulting a physician.
How Is an Intravitreal Injection Performed?
- Preparation: The patient's identity and the eye to be treated are confirmed. The medication, dosage, and allergy information are checked.
- Antisepsis: The area around the eye and the ocular surface are carefully prepared with an appropriate antiseptic such as povidone-iodine.
- Anesthesia: Topical anesthetic drops are applied to make the procedure painless.
- Injection: An eyelid speculum is inserted, and the medication is administered into the vitreous cavity through the white part of the eye using a very fine needle.
During the procedure, the patient may briefly experience pressure, light, a shadow, or the sensation of an image moving inside the eye. Significant pain is not expected because of the anesthesia.
Follow-Up Approach and Injection Frequency
A single injection does not mean that treatment is complete for most chronic retinal diseases. The following follow-up protocols may be used according to the eye's biological response:
| Follow-Up Approach | How Is It Applied? |
|---|---|
| Fixed Interval | Injections are continued at predetermined regular intervals. |
| Treatment as Needed (PRN) | An injection is administered when disease activity is detected during regular follow-up. |
| Treat and Extend | If the disease is controlled, the interval between injections is gradually extended. If activity returns, the interval is shortened. |
Important Warning: If a patient whose condition is well controlled stops treatment without medical guidance, the disease may become active again and cause permanent vision loss.
Possible Risks and Complications
As with all intraocular procedures, some rare risks exist:
- Intraocular Infection (Endophthalmitis): This is a rare but serious complication requiring emergency treatment.
- Increased Intraocular Pressure: This may be temporary. It is monitored closely during repeated treatments or steroid therapy.
- Retinal Tear or Detachment: These are uncommon. Flashes of light, a marked increase in floaters, and a curtain-like sensation are important warning signs.
- Surface Hemorrhage: This may cause a red spot beneath the conjunctiva and usually resolves completely on its own.
⚠️ Emergency Warning: If progressively increasing or severe eye pain, a significant reduction in vision, intense redness, extreme sensitivity to light, discharge, a curtain-like area in the field of vision, or numerous new floaters occur after the injection, an ophthalmologist must be contacted on the same day without waiting for the scheduled follow-up appointment.
Our Approach to Intravitreal Injection Treatment in Izmir
When planning intravitreal injection treatment at our clinic in Izmir, we do not focus solely on the name of the medication. Accurate diagnosis, regular OCT monitoring, appropriate medication storage and preparation, sterile administration, accessibility in emergencies, and the long-term treatment plan are considered together.
During the examination, we openly discuss the name of the disease, the purpose of the injection, and the alternatives. The aim is to protect your eye health at the highest possible level and safely control the course of retinal diseases.





































